Hey everybody, I am very excited today to have one of the heroes of the age. Dr. Harry Rich from Yale and Dr. Rich is a MD, he's a PhD, he is the renowned professor of epidemiology at Yale School of Public Health.

He is perhaps the world's leading authority or one of them in the analysis of aggregate clinical data.

And on evaluating research data and study designs, he has published over 300 articles, has 40,000 citations on Google Scholar Dr. Rich concluded that there is unequivocal evidence for the early and safe use of hydroxychloroquine early on.

And I think it may of the pandemic he published a very, very influential matter of view, looking at all of the studies at that time on hydroxychloroquine.

And he was urging public health authorities all over the country to look at hydroxychloroquine to use it as an early intervention, the reaction of the medical cartel was to silence him and to try to discredit him.

I'm very, very happy that they haven't succeeded. Welcome back to the show Dr. Rich. Thank you.

Thank you. Great to be with you.

One of the things I want to start out with is that your own colleagues in the Yale School of Public Health, I think 20 of them signed a letter or petition about you.

And one, their big complaint about you was that you were a renowned as a cancer specialist, which they were willing to can see that you were the leading authority on the relationship between certain exposures and certain cancers, but they said that you did not know anything about epidemiology and therefore you had no real platformer standing to talk about hydroxychloroquine.

And your matter of view was therefore somehow discredited. How do you respond to that?

Well, in reality, they did not do due diligence. They didn't do their homework about me. They failed to understand that my PhD was in mathematical modeling of infectious epidemics. And I published in that, but even more so, what I published about the efficacy of the medication.

It has nothing to do with infectious diseases at all. It's about drug efficacy. And I've done plenty of those kinds of analyses in all of my studies that are cancer related studies.

And so for them to extrapolate from infectious epidemic processes of viruses to worrying about whether a drug is effective is a misrepresentation, misunderstanding of what exactly was being analyzed in that paper.

And they provided no counter evidence and early outpatient COVID illness and preventing hospitalization and mortality.

And I say, you had done a good job and you were running NIH in the COVID or in national countermeasures. What would you advise the doctors would be the best care at this point with everything that we know about eye-re-medium hydroxychloroquine of steroids? What would you say is standard care?

So what we've learned a number of different things as time has progressed over the pandemic. At first we thought that only high risk patients, meaning people over say age 70 with chronic conditions or obesity or diabetes and so on, needed to have early treatment and that everybody else, if they got sick, could survive at home.

And if they got short of breath and weren't surviving, then they would be treated also. However, we learned after a while that there are some patients who will survive that way but not do so well and may have protracted what's called long COVID or remain with symptoms.

And it may be more reasonable since these treatments that we have acquired evidence of their efficacy and very low cost.

It may be more reasonable to treat people starting at much lower ages. In fact, maybe even everybody because the treatments are as long as they're not contraindicated if people don't have the few infrequent conditions that might suggest not to use these drugs.

The drugs are extremely well tolerated by the great majority of entire population. Hydroxychloroquine is recommended to be used in formalaria, for example, impregnant women and children and people with other diseases and so on. It's very well tolerated. It's been used for 50 years by hundreds of millions of people.

But now we know there's more than that. So people can be treated with hydroxychloroquine, Ivermectin, antibiotics, such as doxycycline or acytheramysin. We also know that culture scene seems to provide benefit when used in outpatients, fluvoxamine has been found in a few studies now to provide benefit from vaccine, which is not available in North America, but has been seen in randomized trials elsewhere in the world.

Provides benefit and steroids. And so we have a whole now armamentarium of things to use early on in treatment of COVID that will prevent hospitalization and mortality for the great majority of people who get treated and that is our first step to use.

...